Related Experiment Video
Updated: Jun 19, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Long-term prognosis of pediatric patients with relapsing acute disseminated encephalomyelitis
Soe Mar1, Jason Lenox, Tammie Benzinger
1Department of Pediatric and Developmental Neurology, Washington University School of Medicine, St Louis, Missouri 63110, USA. mars@neuro.wustl.edu
Insights
Children diagnosed with acute disseminated encephalomyelitis (ADEM) using strict criteria have a good long-term prognosis. Even with relapses, the risk of developing multiple sclerosis is low, indicating a generally benign outcome.
Area of Science:
- Pediatric Neurology
- Neuroimmunology
- Demyelinating Diseases
Background:
- Long-term prognosis data for acute disseminated encephalomyelitis (ADEM) are inconsistent due to varied definitions.
- Standardized criteria are needed to accurately assess the long-term outcomes of pediatric ADEM.
Purpose of the Study:
- To determine the long-term prognosis of pediatric acute disseminated encephalomyelitis (ADEM) using strict International Pediatric Multiple Sclerosis Study Group criteria.
- To specifically evaluate the prognosis of relapsing cases within this cohort.
Main Methods:
- Retrospective analysis of 86 children with a first central nervous system inflammatory demyelinating disease event.
- Strict application of International Pediatric Multiple Sclerosis Study Group criteria for ADEM diagnosis.
- Long-term follow-up, averaging 9.2 years for all ADEM patients and 12.8 years for relapsing cases.
Main Results:
- 33 patients (38%) met the criteria for ADEM, with 9 experiencing relapses.
- The overall risk of relapse was 27%.
- The risk of developing multiple sclerosis from ADEM was low at 6%; all relapsing cases showed a benign course despite initial relapses.
Conclusions:
- Strict diagnostic criteria for pediatric ADEM are crucial for consistent prognostic evaluation.
- Pediatric ADEM, even with relapses, generally follows a benign long-term course with a low risk of developing multiple sclerosis.
- Prolonged follow-up confirms favorable outcomes for children diagnosed with ADEM.
Abstract:
Although long-term follow-up data are available for cases with acute disseminated encephalomyelitis, the findings range widely because of the lack of consistent definitions. Using the International Pediatric Multiple Sclerosis Study Group definitions strictly, we determined the long-term prognosis of children with acute disseminated encephalomyelitis, especially concerning relapsing cases. In our cohort of 86 children who presented with a first event of inflammatory demyelinating disease of central nervous system, 33 patients (38%) met the Study Group criteria for acute disseminated encephalomyelitis of which 9 patients had relapses. The mean follow-up duration was 12.8 years for relapsing cases and 9.2 years for all patients with acute disseminated encephalomyelitis. The risk of developing relapses is 27% but the risk of developing multiple sclerosis from acute disseminated encephalomyelitis is low at 6%. All relapsing cases had a benign course on prolonged follow-up, in spite of multiple relapses in the first 3 years.
Related Concept Videos
Rocky Mountain Spotted Fever
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction
Rabies
Poliomyelitis
